EACC Welcomes New Member Guerbet
June 25, 2021
The EACC is delighted to welcome Consul member Guerbet.
Guerbet builds lasting relationships so that it enables people to live better. The Company is a leader in medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging. A pioneer since 95 years in the field of contrast media with over 2,600 people globally, Guerbet is continuously innovating with 10% of revenue dedicated to Research & Development and four centers in France, Israel and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €712 million in revenue in 2020.
For more information, please visit www.guerbet.com.
Guerbet builds lasting relationships so that it enables people to live better. The Company is a leader in medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging. A pioneer since 95 years in the field of contrast media with over 2,600 people globally, Guerbet is continuously innovating with 10% of revenue dedicated to Research & Development and four centers in France, Israel and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €712 million in revenue in 2020.
For more information, please visit www.guerbet.com.
